CMS
54
-4
DE
40
-2
IR
55
-6
EXC
34
-3
FLR
59
4
DOV
57
-2
CSCO
56
3
BBY
40
2
ITW
61
2
MAC
62
-3
MA
58
3
SYK
60
9
ACN
38
2
AVB
42
-3
CI
52
7
D
38
-2
SE
52
2
STX
50
-2
AMGN
39
-2
ADI
49
3
CMS
54
-4
DE
40
-2
IR
55
-6
EXC
34
-3
FLR
59
4
DOV
57
-2
CSCO
56
3
BBY
40
2
ITW
61
2
MAC
62
-3
MA
58
3
SYK
60
9
ACN
38
2
AVB
42
-3
CI
52
7
D
38
-2
SE
52
2
STX
50
-2
AMGN
39
-2
ADI
49
3
Financhill
Back

Hikma Pharmaceuticals PLC Quote, Financials, Valuation and Earnings

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Sell
43

HKMPF
Hikma Pharmaceuticals PLC

Last Price:
25.07
Seasonality Move:
0.12%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Hikma Pharmaceuticals PLC Price Quote

$25.07

Hikma Pharmaceuticals PLC Key Stats

Sell
43
Hikma Pharmaceuticals PLC (HKMPF) is a Sell
Day range:
$25.07 - $25.07
52-week range:
$21.28 - $26.50
Dividend yield:
3.15%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
0
Avg. volume:
13
1-year change:
7.18%
Market cap:
$5.6B
Revenue:
$2.9B
EPS:
$0.85

How Much Does Hikma Pharmaceuticals PLC Make?

Is Hikma Pharmaceuticals PLC Growing As A Company?

Data Unavailable

Hikma Pharmaceuticals PLC Stock Price Performance

What Is Hikma Pharmaceuticals PLC 52-Week High & Low?

Hikma Pharmaceuticals PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Hikma Pharmaceuticals PLC?

Is Hikma Pharmaceuticals PLC Cash Flow Positive?

  • What Is HKMPF Cash Flow From Operations?
    Cash flow from operations (TTM) is $737M
  • What Is Hikma Pharmaceuticals PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$337M
  • What Is Hikma Pharmaceuticals PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$333M

Hikma Pharmaceuticals PLC Return On Invested Capital

  • Is Management Doing A Good Job?
    HKMPF return on invested capital is 5.62%
  • What Is Hikma Pharmaceuticals PLC Return On Assets?
    ROA measures how assets are converting to revenues and is 4.14%
  • What Is HKMPF Return On Equity?
    ROE is a measure of profitability and is 8.69%

Hikma Pharmaceuticals PLC Earnings Date & Stock Price

Hikma Pharmaceuticals PLC Competitors

Hikma Pharmaceuticals PLC Dividend Yield

Hikma Pharmaceuticals PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many HKMPF shares are owned by institutional investors?
    89M HKMPF shares are owned by institutional investors
  • How many HKMPF shares are owned by insiders?
    0 HKMPF shares are owned by insiders